{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:56:31Z","timestamp":1792821391263,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.canlet.2009.06.001","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T06:36:26Z","timestamp":1248330986000},"page":"91-97","source":"Crossref","is-referenced-by-count":102,"title":["Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer"],"prefix":"10.1016","volume":"287","author":[{"given":"Hai-Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.06.001_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2009.06.001_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2009.06.001_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.micinf.2004.02.020","article-title":"Foxp3: a critical regulator of the development and function of regulatory T cells","volume":"6","author":"Hori","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.canlet.2009.06.001_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fonteno","year":"2003","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.canlet.2009.06.001_bib5","first-page":"766","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"Yisong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.06.001_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","article-title":"Foxp3 expression in human cancer cells","volume":"6","author":"Karanikas","year":"2008","journal-title":"J. Transl. Med."},{"issue":"17","key":"10.1016\/j.canlet.2009.06.001_bib7","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2009.06.001_bib8","first-page":"3765","article-title":"FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2","volume":"117","author":"Zuo","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2009.06.001_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.cell.2007.04.034","article-title":"FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2\/ErbB2 oncogene","volume":"129","author":"Zuo","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2009.06.001_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1538-7836.2005.01781.x","article-title":"In-cell western assay: a new approach to visualize tissue factor in human monocytes","volume":"4","author":"Egorina","year":"2006","journal-title":"J. Throm. Haemost."},{"issue":"23","key":"10.1016\/j.canlet.2009.06.001_bib11","first-page":"8231","article-title":"The expression of the regulatory T cell specific Forkhead Box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer","volume":"11","author":"Dominik","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.06.001_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2003","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.canlet.2009.06.001_bib13","first-page":"1495","article-title":"Human FOX gene family","volume":"25","author":"Katoh","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2009.06.001_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hepres.2004.12.006","article-title":"CDK2\/4 regulates retinoic acid-induced G1 arrest in hepatocellular carcinoma cells","volume":"31","author":"Jung","year":"2005","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2009.06.001_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/gyno.2001.6388","article-title":"Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications","volume":"83","author":"Davidson","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2009.06.001_bib16","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.25011\/cim.v31i1.3136","article-title":"Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia","volume":"31","author":"Zhong","year":"2008","journal-title":"Clin. Invest. Med."},{"issue":"7","key":"10.1016\/j.canlet.2009.06.001_bib17","first-page":"361","article-title":"Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma","volume":"122","author":"Reitmaier","year":"2000","journal-title":"ZBL Gynakol."},{"key":"10.1016\/j.canlet.2009.06.001_bib18","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 with 4EBP1\/eIF4E","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev."},{"issue":"14","key":"10.1016\/j.canlet.2009.06.001_bib19","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","article-title":"RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model","volume":"13","author":"Mabuchi","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2009.06.001_bib20","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-06-4490","article-title":"RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer","volume":"67","author":"Mabuchi","year":"2007","journal-title":"Cancer Res."},{"issue":"9637","key":"10.1016\/j.canlet.2009.06.001_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.canlet.2009.06.001_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ejca.2008.02.043","article-title":"Blocking on the CXCR4\/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells","volume":"4","author":"Hashimoto","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"20","key":"10.1016\/j.canlet.2009.06.001_bib23","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1158\/0008-5472.CAN-06-0802","article-title":"Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells","volume":"66","author":"Cao","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2009.06.001_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ygyno.2006.09.004","article-title":"Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer","volume":"104","author":"Sillanp\u00e4\u00e4","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2009.06.001_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000110426","article-title":"Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer","volume":"28","author":"Sillanp\u00e4\u00e4","year":"2007","journal-title":"Tumour Biol."},{"key":"10.1016\/j.canlet.2009.06.001_bib26","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0959-8049(00)00156-8","article-title":"Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis","volume":"36","author":"Curran","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"17","key":"10.1016\/j.canlet.2009.06.001_bib27","first-page":"5224","article-title":"Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation","volume":"63","author":"Belotti","year":"2003","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.canlet.2009.06.001_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20040058","article-title":"Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappa B site","volume":"381","author":"Ogawa","year":"2004","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.canlet.2009.06.001_bib29","first-page":"239","article-title":"NF-kappa B, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer","volume":"51","author":"Altinoz","year":"2004","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2009.06.001_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.onc.1206323","article-title":"Inhibition of constitutive NF-\u03baB activity by I\u03baB\u03b1M suppresses tumorigenesis","volume":"22","author":"Fujioka","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2009.06.001_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/B:CLIN.0000024751.73174.c2","article-title":"A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation","volume":"21","author":"Kobayashi","year":"2004","journal-title":"Clin. Exp. Metast."},{"key":"10.1016\/j.canlet.2009.06.001_bib32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clinbiochem.2004.05.013","article-title":"The urokinase plasminogen activator system: a rich source of tumor markers for the individualized management of patients with cancer","volume":"37","author":"Duffy","year":"2004","journal-title":"Clin. Biochem."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509004054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509004054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:56:47Z","timestamp":1558443407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509004054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0304383509004054"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.06.001","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}